checkAd

    Lexaria - Top Marijuana Investment! - 500 Beiträge pro Seite

    eröffnet am 17.07.14 21:43:21 von
    neuester Beitrag 09.12.14 13:10:46 von
    Beiträge: 10
    ID: 1.196.514
    Aufrufe heute: 0
    Gesamt: 959
    Aktive User: 0

    ISIN: US52886N3070 · WKN: A2ACB4
    0,2249
     
    USD
    -10,68 %
    -0,0269 USD
    Letzter Kurs 12.01.21 Nasdaq OTC

    Werte aus der Branche Pharmaindustrie

    WertpapierKursPerf. %
    1,2000+471,16
    0,5699+54,03
    13,110+38,44
    1,8250+35,19
    1,1514+30,84
    WertpapierKursPerf. %
    40,23-12,54
    4,5001-13,46
    1,4900-15,82
    36,70-22,87
    2,7280-29,14

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 17.07.14 21:43:21
      Beitrag Nr. 1 ()
      Kann man mal auf die Watchliste setzen!


      http://www.lexariaenergy.com/
      Avatar
      schrieb am 18.07.14 09:16:57
      Beitrag Nr. 2 ()
      hmmmmmmmmmmm, kannst du mal mehr dazu bringen ?
      3 Antworten
      Avatar
      schrieb am 18.07.14 09:30:28
      Beitrag Nr. 3 ()
      Antwort auf Beitrag Nr.: 47.331.432 von androidplayer am 18.07.14 09:16:57
      Marijuaaaaana!
      2 Antworten
      Avatar
      schrieb am 18.07.14 09:35:15
      Beitrag Nr. 4 ()
      Antwort auf Beitrag Nr.: 47.331.540 von Popeye82 am 18.07.14 09:30:28schon probiert ??????????
      1 Antwort
      Avatar
      schrieb am 18.07.14 11:19:48
      Beitrag Nr. 5 ()
      Antwort auf Beitrag Nr.: 47.331.582 von androidplayer am 18.07.14 09:35:15
      eingefleischte strategische Value Investoren wissen Bescheid!
      Von Denen wer keine weitere Frage gekommen!!!

      Trading Spotlight

      Anzeige
      Zwei Gaps, wieder 300% und Gap-Close in Tagen (100%)?mehr zur Aktie »
      Avatar
      schrieb am 18.07.14 11:35:10
      Beitrag Nr. 6 ()
      wer wäre keine von denen wenn ?
      Avatar
      schrieb am 24.11.14 17:59:42
      Beitrag Nr. 7 ()
      Lexaria Develops Proprietary Cannabidiol Technology
      VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) - A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy. Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their seizure rates drop by more than 50%. Four patients (17%) had no seizures for the last month of treatment.

      Lexaria (CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative health company developing Cannabidiol (CBD)-infused products. Lexaria may increase its ownership position to 75% at a later date.

      Link: http://globenewswire.com/news-release/2014/11/24/685834/1010…

      Lexaria continues to pursue the Health Canada MMPR Licensed Producer status by way of its joint venture in Burlington Ontario with Enertopia Corp. (OTCBB: ENRT)

      Link: http://www.wallstreet-online.de/diskussion/1202767-1-10/ener…
      Avatar
      schrieb am 24.11.14 18:13:49
      Beitrag Nr. 8 ()
      Lexaria Launch Medical Advisory Board

      By Ryan Allway - cannabisfn.com - November 20th, 2014

      Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce that it and joint venture partner Lexaria Corp (LXRP) have launched a formal Medical Advisory Board to educate and advocate on behalf of all those who have medical needs that may be able to be met through the understanding and use of medical marijuana or through the use of cannabidiol (CBD) extracted from Industrial Hemp.

      Link: http://www.cannabisfn.com/enertopia-lexaria-launch-medical-a…

      Siehe auch: http://www.wallstreet-online.de/diskussion/1202767-1-10/ener…
      Avatar
      schrieb am 05.12.14 12:27:09
      Beitrag Nr. 9 ()
      What are the Support Levels for Lexaria Corp (OTCMKTS:LXRP) ?
      Lexaria Corp (OTCMKTS:LXRP) recently made a nice move up after hitting a low of $0.045 in early November. The stock saw highs of $0.11 and has been consolidating a few pennies under that recently. The move is welcome to shareholders who have endured months of downward drift since LXRP highs of $0.785 back in March.

      LXRP made a spectacular run earlier this year off its $0.003 low’s to highs of $0.785 per share after the Company entered the red hot Cannabis sector.

      In September the JV reported that they had submitted the Health Canada MMPR Licensed Producer application in July to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. The Company is seeking a Ready to Build letter from Health Canada.

      Lexaria has been trading on the bb’s for some time; the Company was initially registered in Nevada in 2005 to explore and develop oil and gas assets in low-risk areas of North America. The Company still owns significant oil production in Mississippi, producing oil from wells at the Belmont Lake oil field.

      LXRP still receives revenues from these wells reporting $463,798 in revenues for the 9 months ended July 1, 2014. The Company says they have earned a total of $3.5 million oil production revenues since their inception.





      In November LXRP acquired 51% of PoViva Corp. PoViva literally means “Taking in Life” PoViva uses a patent pending process to bind active CBD ingredients with a lipid, allowing for a more efficient and comforting delivery of the CBD than competing products that do not have the benefit of our patent-pending process.

      PoViva owns two patents pending that govern the process used to infuse the CBD into food products, and both patents pending are part of the acquisition. An initial cash payment has been made to PoViva and Lexaria currently has sufficient cash resources to completely fund and launch the acquisition. Lexaria does not require any equity financing to complete the transaction.

      Later in November LXRP issued a letter to shareholders in which they announced their plan to launch a line of premium products relying on their patent pending CBD-infusion process, to bring CBD’s into the mainstream. Because CBD’s do not have psychoactive properties we expect our products to appeal to the widest possible customer base. Initially we will focus our sales efforts across the continental USA.

      Lexaria has commissioned a new website for the effort and plans to begin working on traditional retail sales channels and will work to continually develop those “bricks and mortar” sales methods. Also early in 2015 we hope to add our next CBD-based product line.

      Conclusion:
      LXRP is slowly trending up on accelerating volume; when LXRP moves investors pay attention; back in March LXRP went parabolic running from sub pennies to $0.785 a share. The stock collapsed since those heady days when pot stocks ruled the bb’s; it all ended when CANN got halted and an entire sector lost the wind in its sails.

      Pot stocks are beginning to heat up again as Marijuana was legalized in Alaska, Oregon and Washington D.C and as they do LXRP is one to watch; the Company is led by CEO Chris Bunker who seems to have a good plan moving forward.

      Link: http://www.microcapdaily.com/what-are-the-support-levels-for…
      Avatar
      schrieb am 09.12.14 13:10:46
      Beitrag Nr. 10 ()
      Lexaria Updates Burlington License Application
      KELOWNA, BC—December 9, 2014 - Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce progress on the Burlington, Ontario MMPR license application.

      Health Canada has advised our joint venture partner Enertopia Corp (ENRT) that the Burlington, Ontario application
      has advanced to the Enhanced Screening Stage of the application process.

      Link: http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LE…


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      Lexaria - Top Marijuana Investment!